Cargando…
Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial
BACKGROUND: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback u...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433028/ https://www.ncbi.nlm.nih.gov/pubmed/25928870 http://dx.doi.org/10.1186/s13063-015-0683-4 |
_version_ | 1782371570793054208 |
---|---|
author | Mayer, Kerstin Wyckoff, Sarah Nicole Fallgatter, Andreas J Ehlis, Ann-Christine Strehl, Ute |
author_facet | Mayer, Kerstin Wyckoff, Sarah Nicole Fallgatter, Andreas J Ehlis, Ann-Christine Strehl, Ute |
author_sort | Mayer, Kerstin |
collection | PubMed |
description | BACKGROUND: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. METHODS/DESIGN: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. DISCUSSION: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. TRIAL REGISTRATION: This study is registered with the German Registry of Clinical Trials: DRKS00006767, date of registration: 8 October 2014. |
format | Online Article Text |
id | pubmed-4433028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44330282015-05-16 Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial Mayer, Kerstin Wyckoff, Sarah Nicole Fallgatter, Andreas J Ehlis, Ann-Christine Strehl, Ute Trials Study Protocol BACKGROUND: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. METHODS/DESIGN: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. DISCUSSION: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. TRIAL REGISTRATION: This study is registered with the German Registry of Clinical Trials: DRKS00006767, date of registration: 8 October 2014. BioMed Central 2015-04-18 /pmc/articles/PMC4433028/ /pubmed/25928870 http://dx.doi.org/10.1186/s13063-015-0683-4 Text en © Mayer et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Mayer, Kerstin Wyckoff, Sarah Nicole Fallgatter, Andreas J Ehlis, Ann-Christine Strehl, Ute Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title | Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title_full | Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title_fullStr | Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title_full_unstemmed | Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title_short | Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial |
title_sort | neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (adhd): study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433028/ https://www.ncbi.nlm.nih.gov/pubmed/25928870 http://dx.doi.org/10.1186/s13063-015-0683-4 |
work_keys_str_mv | AT mayerkerstin neurofeedbackasanonpharmacologicaltreatmentforadultswithattentiondeficithyperactivitydisorderadhdstudyprotocolforarandomizedcontrolledtrial AT wyckoffsarahnicole neurofeedbackasanonpharmacologicaltreatmentforadultswithattentiondeficithyperactivitydisorderadhdstudyprotocolforarandomizedcontrolledtrial AT fallgatterandreasj neurofeedbackasanonpharmacologicaltreatmentforadultswithattentiondeficithyperactivitydisorderadhdstudyprotocolforarandomizedcontrolledtrial AT ehlisannchristine neurofeedbackasanonpharmacologicaltreatmentforadultswithattentiondeficithyperactivitydisorderadhdstudyprotocolforarandomizedcontrolledtrial AT strehlute neurofeedbackasanonpharmacologicaltreatmentforadultswithattentiondeficithyperactivitydisorderadhdstudyprotocolforarandomizedcontrolledtrial |